Facilitated By

San Antonio Medical Foundation

News

  • Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio ... Immutep is a late-stage biotechnology company developing novel ...

  • Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing ...

    HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO) ... San Antonio News ...

  • San Antonio consumers continued to eke out more fall spending in the month of October

    Bioscience-Medicine · Border & Immigration · Economy ... San Antonio consumers continued to eke out more fall spending in the month of October.

  • Syantra Inc. to Showcase Breakthrough Research on Immune Reprogramming in Breast ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place December 9–12 ... biotechnology company pioneering a platform to change the way cancer is ...

  • Immutep : to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place in San Antonio, Texas, from December 9-12, 2025. The Phase II study randomised female ...